1 Min Read
Dec 12 (Reuters) - Macrogenics Inc :
* MacroGenics licenses Synthon’s technology to develop an anti-b7-h3 adc
* Additional details of transaction were not disclosed Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.